Certified by Founder Lodge
Syntis Bio
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $38,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide accessible, effective and sustainable solutions
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 02 ,2025 | Series A | $38,000,000 |
BOLD Capital Partners
Safar Partners
Portal Innovations, LLC
Cerberus Capital Management
Woori Venture Partners US
Cerity Partners Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
ValGenesis | $16,000,000 | (Jul 23, 2025)
Nevoya | $9,300,000 | (Jul 23, 2025)
Phlow | $37,000,000 | (Jul 23, 2025)
Delve | $32,000,000 | (Jul 23, 2025)
Composio | $25,000,000 | (Jul 23, 2025)
